Clinical trial
E3 Diabetes - Closing the Gap in Diabetes Control
NCT06643936 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- E3 Diabetes - Closing the Gap in Diabetes Control
- Lead sponsor
- Rush University Medical Center
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- November 18, 2024
- Completion date
- October 1, 2026
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes